Question 1

What is Cytokinetics?

Accepted Answer

Cytokinetics is a Company.

Question 2

How often does Cytokinetics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 26 articles.

Question 3

When was Cytokinetics first tracked by Ergen?

Accepted Answer

First tracked on Oct 31, 2025.

Question 4

When was Cytokinetics last mentioned in news?

Accepted Answer

Last active on Jul 30, 2026.

Question 5

What is Cytokinetics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Cytokinetics in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Cytokinetics?

Accepted Answer

Cytokinetics gets UK approval for aficamten (Jul 30, 2026, 6 articles).

Question 8

How did the "Cytokinetics gets UK approval for aficamten" event impact Cytokinetics?

Accepted Answer

Cytokinetics received marketing authorisation and positive NICE guidance for its drug aficamten in the UK, enabling commercial launch and potential revenue growth.

Question 9

How did the "Grabar Law Office Investigates Multiple Companies" event impact Cytokinetics?

Accepted Answer

Cytokinetics is under investigation by Meitar Law Offices for allegedly making false and misleading statements regarding its New Drug Application for aficamten, specifically failing to include a Risk Evaluation and Mitigation Strategy (REMS) in its initial NDA.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.